CIK 0001706431
- Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812730369
- Phone
- +1 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 4 Open-market sale 10% owner sold 287,736 shares at an average $27.31 ($7,856,738)
- 4 Open-market sale 10% owner sold 182,083 shares at an average $27.26 ($4,964,081)
- 4 Open-market sale Director sold 17,915 shares at $27.38 ($490,549)
- 4 Open-market sale Director sold 17,915 shares at $20.67 ($370,278)
- 4 Open-market sale Director sold 17,915 shares at $21.90 ($392,335)
- 4 Other disposition Director disposed of 1,000,000 shares (other)
- 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
- 4 Other disposition Director disposed of 1,000,000 shares (other)
- 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
- 4 Other disposition Director disposed of 1,000,000 shares (other)
- 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
- 4 Other disposition Director disposed of 500,000 shares (other)
- 4 Other disposition 10% owner disposed of 500,000 shares (other)
- 4 Open-market sale 10% owner sold 130,364 shares at an average $27.97 ($3,645,758)
- 4 Other disposition Director disposed of 1,500,000 shares (other)
- 4 Other disposition 10% owner disposed of 1,500,000 shares (other)
- 4 Exercise or conversion EVP, Research & CSO acquired 78,093 shares (option exercise)
- 4 Open-market sale Director sold 17,915 shares at $30.29 ($542,685)
- 4 Open-market sale Chief Medical Officer sold 5,000 shares at $30.00 ($150,000)
- 4 Open-market sale Director sold 5,000 shares at $30.00 ($150,000)
Page 11 of 25 · 491 filings